Hematological improvement during iron-chelation therapy in myelodysplastic syndromes: the experience of the “Rete Ematologica Lombarda”.

Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1.

Clinical evaluation of extra-hematologic comorbidity in myelodysplastic syndromes: ready-to-wear versus made-to-measure tool.